Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ENGN compared with LXRX: revenue, margins and what each company keeps, and the suppliers and customers both name
ENGN
enGene Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
LXRX
Lexicon Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ENGN
enGene Therapeutics Inc.
vs
LXRX
Lexicon Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
ENGN
enGene Therapeutics Inc.
Change
1.50
▼
−1.86%
· post 1.50
Mkt cap
$102.5M
Revenue
—
Revenue
—
LXRX
Lexicon Pharmaceuticals, Inc.
Change
1.42
▼
−4.05%
· post 1.42
Closed
Oct 30 '26
Mkt cap
$631.8M
Revenue
$692,000
Q2 FY26
Revenue
$144M
FY25
vs
Compare
Closed
Oct 30 '26
ENGN
enGene Therapeutics Inc.
vs
LXRX
Lexicon Pharmaceuticals, Inc.
1.50
▼
−1.86%
post 1.50
Price
1.42
▼
−4.05%
post 1.42
$102.5M
Mkt cap
$631.8M
—
Revenue
$692,000
Q2 FY26
—
Revenue
$144M
FY25
Change
Change
ENGN
1.50
▼
−1.86%
vs
LXRX
1.42
▼
−4.05%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ENGN: latest quarter not drawable. LXRX: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ENGN
0
None
Shared
0
No disclosed counterparties: ENGN.
Only LXRX
12
BMY
Bristol-Myers Squibb
supplier
VTRS
Viatris
customer
NVO
Novo Nordisk A/S
customer
—
RFL NO.4 Limited Partnership
unlisted
supplier
8 more · LXRX chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ENGN, solid
LXRX, dashed